Moderna expects to make 20 mln doses of coronavirus vaccine by 2020 end

Credit: REUTERS/Brian Snyder

Moderna Inc said on Friday it expects to produce 20 million doses of its experimental coronavirus vaccine by the end of the year.

Sept 18 (Reuters) - Moderna Inc MRNA.O said on Friday it expects to produce 20 million doses of its experimental coronavirus vaccine by the end of the year.

The company continues to expect to make 500 million to 1 billion doses of the vaccine in 2021, Moderna said in a filing with the U.S. securities regulators. (https://bit.ly/35PkSnc)

(Reporting by Manas Mishra in Bengaluru; Editing by Shounak Dasgupta)

((Manas.Mishra@thomsonreuters.com; www.twitter.com/Manasmishra24; within U.S. +1 646 223 8780, outside U.S. +91 806749 2709))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

MRNA

Reuters

Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV.

Learn More